Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Enhancement of brain plasticity and recovery of locomotive function after lumbar spinal cord stimulation in combination with gait training with partial weight support in rats with cerebral ischemia.

Brain research | 2017

Lumbar spinal cord stimulation (LSCS) is reportedly effective for the recovery of locomotive intraspinal neural network, motor cortex and basal ganglia in animals with complete spinal cord injury and parkinsonism. We evaluated the effect of LSCS in combination with gait training on the recovery of locomotive function and brain plasticity using a rat model of brain ischemia. Adult male Sprague Dawley rats with ischemia were randomly assigned into one of four groups: sham treatment (group 1), LSCS only (group 2), LSCS with gait training and 50% (group 3) and 80% (group 4) of body weight support. Evaluations before randomization and 4weeks after intervention included motor scoring index, real-time PCR and Western blot. Motor scoring index was significantly improved after the intervention in groups 2 and 3. The ratio of phospho-protein kinase C (PKC) to PKC measured in the infarcted area tended to be higher in groups 3 and 4. Protein expression of mGluR2 and mRNA expression of mGluR1 measured in the contralateral cortex were lower in groups 3 and 4. The ratio of phospho-Akt to Akt and mRNA expression of vascular endothelial growth factor measured in the ischemic border zone were higher in group 2. The mRNA expression of MAP1b measured in the infarcted area was significantly higher in group 2. The findings suggest that LSCS and gait training with an adequate amount of body weight support may promote brain plasticity and facilitate the functional recovery.

Pubmed ID: 28237545 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Metabotropic Glutamate Receptor 2 antibody [mG2Na-s] (antibody)

RRID:AB_302021

This monoclonal targets Metabotropic Glutamate Receptor 2

View all literature mentions

Phospho-Akt (Ser473) (587F11) Mouse mAb (antibody)

RRID:AB_331158

This monoclonal targets Phospho-Akt (Ser473) (587F11) Mouse mAb

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

Anti-PKC??, clone M4 (antibody)

RRID:AB_2284233

This monoclonal targets Prkca

View all literature mentions

PKC alpha (phospho S657 + Y658) antibody (antibody)

RRID:AB_2237450

This polyclonal targets PKC alpha (phospho S657 + Y658)

View all literature mentions

Crl:CD(SD) (organism)

RRID:RGD_734476

Rattus norvegicus with name Crl:CD(SD) from RGD.

View all literature mentions

Metabotropic Glutamate Receptor 2 antibody [mG2Na-s] (antibody)

RRID:AB_302021

This monoclonal targets Metabotropic Glutamate Receptor 2

View all literature mentions

Metabotropic Glutamate Receptor 2 antibody [mG2Na-s] (antibody)

RRID:AB_302021

This monoclonal targets Metabotropic Glutamate Receptor 2

View all literature mentions